Versant Capital Management’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Other funds holding EVH
Versant Capital Management's EVH Position: Q3 2026 in Review
Versant Capital Management sold out of Evolent Health (EVH) in Q3 2026, closing a stake of 2,650 shares — an estimated $14.4K sold.
Versant Capital Management first reported a position in EVH in Q1 2019 and held it in 27 quarters. The position peaked at $14.4K in Q2 2026. 193 funds tracked by Wall St. Rank hold EVH as of Q3 2026.
- Versant Capital Management reported no remaining Evolent Health position as of Q3 2026 after selling out during the quarter.
- Versant Capital Management sold 2,650 Evolent Health shares in Q3 2026, an estimated $14.4K.
- Versant Capital Management first reported a position in Evolent Health in Q1 2019 and held it in 27 quarters.
- Versant Capital Management's Evolent Health position peaked at $14.4K in Q2 2026.
- 193 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.